{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T20:23:07Z","timestamp":1791490987246,"version":"4.3.4"},"reference-count":53,"publisher":"MDPI AG","issue":"4","license":[{"start":{"date-parts":[[2025,6,27]],"date-time":"2025-06-27T00:00:00Z","timestamp":1750982400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Infectious Disease Reports"],"abstract":"<jats:p>Background: Although COVID-19 vaccination has been effective in reducing severe illness and mortality, its differential clinical behavior in vaccinated and unvaccinated individuals during the early stages of the pandemic\u2014especially in settings with partial coverage and real-world conditions\u2014remains insufficiently characterized. Objective: To assess differences in clinical presentation, comorbidity prevalence, hospitalization, and mortality between vaccinated and unvaccinated patients diagnosed with SARS-CoV-2 during the early phase of the pandemic. Methods: An analytical cross-sectional study was conducted using 4625 electronic medical records of patients diagnosed with COVID-19 in Guerrero, Mexico, between 1 January and 31 December 2021. Variables included vaccination status, age, sex, comorbidities, symptom severity, clinical outcomes, and mortality. Statistical analyses involved chi-square tests, logistic regression for hospitalization probability, and Cox proportional hazards models for mortality risk. Results: Of the patients analyzed, 31.45% had received at least one vaccine dose. Fever, headache, cough, and anosmia were more frequent among vaccinated individuals (p &lt; 0.001). Prostration and chest pain were strongly associated with hospitalization in both groups. In unvaccinated patients, smoking (OR = 4.75), obesity (OR = 3.85), and hypertension (OR = 2.94) increased hospitalization risk. Among vaccinated patients, diabetes mellitus (OR = 3.62) and hypertension (OR = 2.88) were key predictors. Vaccination was significantly associated with lower odds of hospitalization (OR = 0.38; 95% CI: 0.26\u20130.55) and reduced mortality risk (HR = 0.24; 95% CI: 0.08\u20130.71). Conclusions: Vaccination status was a significant protective factor for both hospitalization and mortality; however, clinical symptoms and comorbidity-related risks varied, highlighting the need for individualized patient management strategies.<\/jats:p>","DOI":"10.3390\/idr17040074","type":"journal-article","created":{"date-parts":[[2025,6,27]],"date-time":"2025-06-27T05:29:58Z","timestamp":1751002198000},"page":"74","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Impact of COVID-19 Vaccination on Hospitalization and Mortality: A Comparative Analysis of Clinical Outcomes During the Early Phase of the Pandemic"],"prefix":"10.3390","volume":"17","author":[{"given":"Brenda","family":"Gardu\u00f1o-Orbe","sequence":"first","affiliation":[{"name":"Unidad de Medicina Familiar N\u00famero 26, Instituto Mexicano del Seguro Social, Acapulco 39700, Guerrero, Mexico"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paola Selene","family":"Palma-Ram\u00edrez","sequence":"additional","affiliation":[{"name":"Unidad de Medicina Familiar No. 29 con UMAA, Instituto Mexicano del Seguro Social, Acapulco 39906, Guerrero, Mexico"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eduardo","family":"L\u00f3pez-Ortiz","sequence":"additional","affiliation":[{"name":"Subdivisi\u00f3n de Medicina Familiar, Facultad de Medicina, Universidad Nacional Aut\u00f3noma de M\u00e9xico, Ciudad Universitaria 04510, Ciudad de M\u00e9xico, Mexico"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gabriela","family":"Garc\u00eda-Morales","sequence":"additional","affiliation":[{"name":"Unidad de Medicina Familiar N\u00famero 26, Instituto Mexicano del Seguro Social, Acapulco 39700, Guerrero, Mexico"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juan Manuel","family":"S\u00e1nchez-Rebolledo","sequence":"additional","affiliation":[{"name":"Unidad de Medicina Familiar N\u00famero 26, Instituto Mexicano del Seguro Social, Acapulco 39700, Guerrero, Mexico"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexis","family":"Emigdio-Loeza","sequence":"additional","affiliation":[{"name":"Unidad M\u00e9dica de Alta Especialidad N\u00famero 1, Hospital de Especialidades Centro M\u00e9dico Nacional del Baj\u00edo, Instituto Mexicano del Seguro Social, Le\u00f3n de los Aldama 37320, Guanajuato, Mexico"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9158-1095","authenticated-orcid":false,"given":"Anel","family":"G\u00f3mez-Garc\u00eda","sequence":"additional","affiliation":[{"name":"Centro de Investigaci\u00f3n Biom\u00e9dica de Michoac\u00e1n, Instituto Mexicano del Seguro Social, Morelia 58351, Michoac\u00e1n, Mexico"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0280-0012","authenticated-orcid":false,"given":"Geovani","family":"L\u00f3pez-Ortiz","sequence":"additional","affiliation":[{"name":"Subdivisi\u00f3n de Medicina Familiar, Facultad de Medicina, Universidad Nacional Aut\u00f3noma de M\u00e9xico, Ciudad Universitaria 04510, Ciudad de M\u00e9xico, Mexico"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2025,6,27]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"945","DOI":"10.1126\/science.abb8923","article-title":"Rapid COVID-19 Vaccine Development","volume":"368","author":"Graham","year":"2020","journal-title":"Science"},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1038\/s41586-020-2798-3","article-title":"SARS-CoV-2 Vaccines in Development","volume":"586","author":"Krammer","year":"2020","journal-title":"Nature"},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"2603","DOI":"10.1056\/NEJMoa2034577","article-title":"Safety and Efficacy of the BNT162b2 mRNA COVID-19 Vaccine","volume":"383","author":"Polack","year":"2020","journal-title":"N. Engl. J. Med."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1056\/NEJMoa2035389","article-title":"Efficacy and Safety of the mRNA-1273 SARS-CoV-2 Vaccine","volume":"384","author":"Baden","year":"2021","journal-title":"N. Engl. J. Med."},{"key":"ref_5","doi-asserted-by":"crossref","unstructured":"Morgenstern, C., Rawson, T., Hinsley, W., Perez-Guzman, P.N., Bhatt, S., and Ferguson, N.M. (2025). Socioeconomic and Temporal Heterogeneity in SARS-CoV-2 Exposure and Disease in England from May 2020 to February 2023. MedRxiv.","DOI":"10.1101\/2024.11.11.24317098"},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"1546","DOI":"10.1093\/aje\/kwac076","article-title":"Heterogeneity in Spatial Inequities in COVID-19 Vaccination Across 16 Large US Cities","volume":"191","author":"Bilal","year":"2022","journal-title":"Am. J. Epidemiol."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/S0140-6736(20)32661-1","article-title":"Safety and Efficacy of the ChAdOx1 nCoV-19 Vaccine (AZD1222) against SARS-CoV-2: An Interim Analysis of Four Randomised Controlled Trials in Brazil, South Africa, and the UK","volume":"397","author":"Voysey","year":"2021","journal-title":"Lancet"},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"1819","DOI":"10.1016\/S0140-6736(21)00947-8","article-title":"Impact and Effectiveness of mRNA BNT162b2 Vaccine against SARS-CoV-2 Infections and COVID-19 Cases, Hospitalisations, and Deaths Following a Nationwide Vaccination Campaign in Israel: An Observational Study Using National Surveillance Data","volume":"397","author":"Haas","year":"2021","journal-title":"Lancet"},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/S1473-3099(21)00460-6","article-title":"Risk Factors and Disease Profile of Post-Vaccination SARS-CoV-2 Infection in UK Users of the COVID Symptom Study App: A Prospective, Community-Based, Nested, Case-Control Study","volume":"22","author":"Antonelli","year":"2022","journal-title":"Lancet Infect. Dis."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"1474","DOI":"10.1056\/NEJMoa2109072","article-title":"Covid-19 Breakthrough Infections in Vaccinated Health Care Workers","volume":"385","author":"Bergwerk","year":"2021","journal-title":"N. Engl. J. Med."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1038\/s41577-021-00578-z","article-title":"Immunological Mechanisms of Vaccine-Induced Protection against COVID-19 in Humans","volume":"21","author":"Sadarangani","year":"2021","journal-title":"Nat. Rev. Immunol."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1038\/s41586-021-03791-x","article-title":"Systems Vaccinology of the BNT162b2 mRNA Vaccine in Humans","volume":"596","author":"Arunachalam","year":"2021","journal-title":"Nature"},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1016\/S2213-2600(23)00140-6","article-title":"COVID-19 Vaccine Effectiveness and Evolving Variants: Understanding the Immunological Footprint","volume":"11","author":"Zaeck","year":"2023","journal-title":"Lancet Respir. Med."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/j.eimc.2022.11.003","article-title":"Comparative Severity of COVID-19 Cases Caused by Alpha, Delta or Omicron SARS-CoV-2 Variants and Its Association with Vaccination","volume":"42","author":"Mazagatos","year":"2024","journal-title":"Enfermedades Infecc. y Microbiol. Cl\u00ednica"},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1093\/trstmh\/trae082","article-title":"How Well Do Different COVID-19 Vaccines Protect against Different Viral Variants? A Systematic Review and Meta-Analysis","volume":"119","author":"Hoang","year":"2025","journal-title":"Trans. R. Soc. Trop. Med. Hyg."},{"key":"ref_16","doi-asserted-by":"crossref","unstructured":"Camacho-Moll, M.E., Mata-Tijerina, V.L., Guti\u00e9rrez-Salazar, C.C., Silva-Ram\u00edrez, B., Pe\u00f1uelas-Urquides, K., Gonz\u00e1lez-Escalante, L., Escobedo-Guajardo, B.L., Cruz-Luna, J.E., Corrales-P\u00e9rez, R., and G\u00f3mez-Garc\u00eda, S. (2024). The Impact of Comorbidity Status in COVID-19 Vaccines Effectiveness before and after SARS-CoV-2 Omicron Variant in Northeastern Mexico: A Retrospective Multi-Hospital Study. Front. Public Health, 12.","DOI":"10.3389\/fpubh.2024.1402527"},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"ofad500.490","DOI":"10.1093\/ofid\/ofad500.490","article-title":"420. Prevalence of Comorbidities and COVID-19 Vaccination among COVID-19 Deaths","volume":"10","author":"Lyons","year":"2023","journal-title":"Open Forum Infect. Dis."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1038\/s41586-021-03739-1","article-title":"Age-Related Immune Response Heterogeneity to SARS-CoV-2 Vaccine BNT162b2","volume":"596","author":"Collier","year":"2021","journal-title":"Nature"},{"key":"ref_19","doi-asserted-by":"crossref","unstructured":"Yanez, N.D., Weiss, N.S., Romand, J.-A., and Treggiari, M.M. (2020). COVID-19 Mortality Risk for Older Men and Women. BMC Public Health, 20.","DOI":"10.1186\/s12889-020-09826-8"},{"key":"ref_20","unstructured":"UCSF (2025, April 16). Institute For Global Health Sciences. La respuesta de M\u00e9xico al COVID-19: Estudio de caso. Available online: https:\/\/globalhealthsciences.ucsf.edu\/wp-content\/uploads\/2024\/02\/la_respuesta_de_mexico_al_covid_esp.pdf."},{"key":"ref_21","first-page":"e474","article-title":"Variantes de SARS-CoV-2 y Los Casos Asociados a Cuatro Olas Epidemiol\u00f3gicas En Sinaloa, M\u00e9xico","volume":"25","year":"2022","journal-title":"TIP RECQB"},{"key":"ref_22","first-page":"100624","article-title":"The Evolving Landscape of SARS-CoV-2 Vaccination in Mexico: Real-World Evidence in Mexican Pensioners","volume":"27","year":"2023","journal-title":"Lancet Reg. Health\u2014Am."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"598","DOI":"10.21149\/12696","article-title":"Acceptance, Refusal and Hesitancy of COVID-19 Vaccination in Mexico: Ensanut 2020 COVID-19","volume":"63","author":"Carnalla","year":"2021","journal-title":"Salud Publica Mex."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1186\/s12939-022-01685-6","article-title":"Barriers to COVID-19 Vaccination among Older Adults in Mexico City","volume":"21","year":"2022","journal-title":"Int. J. Equity Health"},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"2000045","DOI":"10.2807\/1560-7917.ES.2020.25.3.2000045","article-title":"Detection of 2019 Novel Coronavirus (2019-nCoV) by Real-Time RT-PCR","volume":"25","author":"Corman","year":"2020","journal-title":"Eurosurveillance"},{"key":"ref_26","unstructured":"WHO (2025, May 21). Antigen-Detection in the Diagnosis of SARS-CoV-2 Infection. Available online: https:\/\/www.who.int\/publications\/i\/item\/antigen-detection-in-the-diagnosis-of-sars-cov-2infection-using-rapid-immunoassays."},{"key":"ref_27","doi-asserted-by":"crossref","unstructured":"Ranucci, M., Parati, G., Di Dedda, U., Bussotti, M., Agricola, E., Menicanti, L., Bombace, S., De Martino, F., Giovinazzo, S., and Zambon, A. (2022). When Outcomes Diverge: Age and Cardiovascular Risk as Determinants of Mortality and ICU Admission in COVID-19. J. Clin. Med., 11.","DOI":"10.3390\/jcm11144099"},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1016\/S2215-0366(20)30564-2","article-title":"COVID-19 Vaccination for People with Severe Mental Illness: Why, What, and How?","volume":"8","author":"Mazereel","year":"2021","journal-title":"Lancet Psychiatry"},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"101965","DOI":"10.1016\/j.eclinm.2023.101965","article-title":"Vaccines and Therapeutics for Immunocompromised Patients with COVID-19","volume":"59","author":"Shoham","year":"2023","journal-title":"eClinicalMedicine"},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"2150132721996898","DOI":"10.1177\/2150132721996898","article-title":"Increased COVID-19-Related Fear and Subjective Risk Perception Regarding COVID-19 Affects Behavior in Individuals with Internal High-Risk Diseases","volume":"12","author":"Kohler","year":"2021","journal-title":"J. Prim. Care Community Health"},{"key":"ref_31","first-page":"25","article-title":"Study on Medical Care-Seeking Behaviors and Chronic Comorbidities Based on the Ecology of the Medical Care Model","volume":"2","author":"Zhang","year":"2024","journal-title":"Big Data Anal. Healthc."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1177\/0194599820929185","article-title":"Olfactory Dysfunction and Sinonasal Symptomatology in COVID-19: Prevalence, Severity, Timing, and Associated Characteristics","volume":"163","author":"Speth","year":"2020","journal-title":"Otolaryngol. Head Neck Surg."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"916","DOI":"10.1126\/science.abe6959","article-title":"Model-Informed COVID-19 Vaccine Prioritization Strategies by Age and Serostatus","volume":"371","author":"Bubar","year":"2021","journal-title":"Science"},{"key":"ref_34","unstructured":"Conacyt (2025, May 21). Datos COVID-19 M\u00e9xico. Available online: https:\/\/datos.covid-19.conacyt.mx\/index.php."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"860","DOI":"10.1038\/nature05485","article-title":"Inflammation and Metabolic Disorders","volume":"444","author":"Hotamisligil","year":"2006","journal-title":"Nature"},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"774","DOI":"10.1038\/s42255-021-00407-6","article-title":"Acute and Long-Term Disruption of Glycometabolic Control after SARS-CoV-2 Infection","volume":"3","author":"Montefusco","year":"2021","journal-title":"Nat. Metab."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"1398","DOI":"10.1093\/ntr\/ntab004","article-title":"Impact of Tobacco Smoking on the Risk of COVID-19: A Large Scale Retrospective Cohort Study","volume":"23","author":"Paleiron","year":"2021","journal-title":"Nicotine Tob. Res."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"111532","DOI":"10.1016\/j.jclinepi.2024.111532","article-title":"Using Causal Diagrams within the Grading of Recommendations, Assessment, Development and Evaluation Framework to Evaluate Confounding Adjustment in Observational Studies","volume":"175","author":"McIntyre","year":"2024","journal-title":"J. Clin. Epidemiol."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1513\/AnnalsATS.201808-564PS","article-title":"Control of Confounding and Reporting of Results in Causal Inference Studies. Guidance for Authors from Editors of Respiratory, Sleep, and Critical Care Journals","volume":"16","author":"Lederer","year":"2019","journal-title":"Ann. ATS"},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1038\/s41575-021-00426-4","article-title":"COVID-19 and Liver Disease: Mechanistic and Clinical Perspectives","volume":"18","author":"Marjot","year":"2021","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1016\/S2468-1253(21)00008-X","article-title":"SARS-CoV-2 Vaccination in Patients with Liver Disease: Responding to the next Big Question","volume":"6","author":"Marjot","year":"2021","journal-title":"Lancet Gastroenterol. Hepatol."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1038\/s41586-020-2521-4","article-title":"Factors Associated with COVID-19-Related Death Using OpenSAFELY","volume":"584","author":"Williamson","year":"2020","journal-title":"Nature"},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"2052","DOI":"10.1001\/jama.2020.6775","article-title":"Presenting Characteristics, Comorbidities, and Outcomes Among 5700 Patients Hospitalized With COVID-19 in the New York City Area","volume":"323","author":"Richardson","year":"2020","journal-title":"JAMA"},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"ofae051","DOI":"10.1093\/ofid\/ofae051","article-title":"Real-World Effectiveness of mRNA COVID-19 Vaccines Among US Nursing Home Residents Aged \u226565 Years in the Pre-Delta and High Delta Periods","volume":"11","author":"Lu","year":"2024","journal-title":"Open Forum Infect. Dis."},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1007\/s40121-024-01091-1","article-title":"Evaluating the Effectiveness of mRNA-1273.815 Against COVID-19 Hospitalization Among Adults Aged \u2265 18 Years in the United States","volume":"14","author":"Wilson","year":"2025","journal-title":"Infect. Dis. Ther."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"73","DOI":"10.15585\/mmwr.mm7406a1","article-title":"Interim Estimates of 2024\u20132025 COVID-19 Vaccine Effectiveness Among Adults Aged \u226518 Years\u2014VISION and IVY Networks, September 2024\u2013January 2025","volume":"74","author":"Chickery","year":"2025","journal-title":"MMWR Morb. Mortal. Wkly. Rep."},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"1115","DOI":"10.1007\/s10554-023-02819-9","article-title":"Functional Outcomes in Post COVID-19 Patients with Persistent Dyspnea: Multidisciplinary Approach","volume":"39","author":"Hamdy","year":"2023","journal-title":"Int. J. Cardiovasc. Imaging"},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/S1473-3099(21)00475-8","article-title":"Hospital Admission and Emergency Care Attendance Risk for SARS-CoV-2 Delta (B.1.617.2) Compared with Alpha (B.1.1.7) Variants of Concern: A Cohort Study","volume":"22","author":"Twohig","year":"2022","journal-title":"Lancet Infect. Dis."},{"key":"ref_49","doi-asserted-by":"crossref","unstructured":"Mendes, J.M., Baptista, H., Oliveira, A., Jardim, B., and de Castro Neto, M. (2022). Beyond Comorbidities, Sex and Age Have No Effect on COVID-19 Health Care Demand. Sci. Rep., 12.","DOI":"10.1038\/s41598-022-11376-5"},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"1288","DOI":"10.1056\/NEJMc2200133","article-title":"Protection against the Omicron Variant from Previous SARS-CoV-2 Infection","volume":"386","author":"Altarawneh","year":"2022","journal-title":"N. Engl. J. Med."},{"key":"ref_51","unstructured":"(2025, April 16). UN Research Roadmap for the COVID-19 Recovery. Available online: https:\/\/www.un.org\/en\/coronavirus\/communication-resources\/un-research-roadmap-covid-19-recovery."},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"1205","DOI":"10.1038\/s41591-021-01377-8","article-title":"Neutralizing Antibody Levels Are Highly Predictive of Immune Protection from Symptomatic SARS-CoV-2 Infection","volume":"27","author":"Khoury","year":"2021","journal-title":"Nat. Med."},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"3","DOI":"10.2188\/jea.JE20240082","article-title":"Methodological Tutorial Series for Epidemiological Studies: Confounder Selection and Sensitivity Analyses to Unmeasured Confounding from Epidemiological and Statistical Perspectives","volume":"35","author":"Inoue","year":"2025","journal-title":"J. Epidemiol."}],"container-title":["Infectious Disease Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2036-7449\/17\/4\/74\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T17:59:50Z","timestamp":1760032790000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2036-7449\/17\/4\/74"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6,27]]},"references-count":53,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2025,8]]}},"alternative-id":["idr17040074"],"URL":"https:\/\/doi.org\/10.3390\/idr17040074","relation":{},"ISSN":["2036-7449"],"issn-type":[{"value":"2036-7449","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,6,27]]}}}